Integra LifeSciences Cor... (IART)
22.01
-0.66 (-2.91%)
At close: Feb 20, 2025, 3:59 PM
22.03
0.09%
After-hours: Feb 20, 2025, 04:00 PM EST
undefined% (undefined)
| Bid | 21.52 |
| Market Cap | 1.70B |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -0.09 |
| PE Ratio (ttm) | -244.56 |
| Forward PE | n/a |
| Analyst | Sell |
| Ask | 22.52 |
| Volume | 331,434 |
| Avg. Volume (20D) | 579,569 |
| Open | 22.60 |
| Previous Close | 22.67 |
| Day's Range | 21.88 - 22.85 |
| 52-Week Range | 16.81 - 45.11 |
| Beta | undefined |
About IART
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracrani...
Industry Medical - Devices
Sector Healthcare
IPO Date Aug 16, 1995
Employees 3,946
Stock Exchange NASDAQ
Ticker Symbol IART
Website https://www.integralife.com
Analyst Forecast
According to 7 analyst ratings, the average rating for IART stock is "Sell." The 12-month stock price forecast is $22, which is a decrease of -0.05% from the latest price.
Buy 14.29%
Hold 42.86%
Sell 42.86%
Next Earnings Release
Integra LifeSciences Corporation is scheduled to release its earnings on Feb 25, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 months ago
+25.1%
Integra LifeSciences shares are trading higher aft...
Unlock content with
Pro Subscription
6 months ago
-1.53%
Integra Lifesciences shares are trading lower after Citigroup and BTIG both downgraded the stock from Neutral to Sell. The company recently lowered its FY24 guidance.
